Morepen Laboratories Limited
NSE: MOREPENLAB.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sushil Suri
- Employees
- 2,152
- Headquarters
- Gurugram, India
- IPO year
- 1996
- Market cap
- ₹25.0B
- Website
- https://www.morepen.com
Loading MOREPENLAB…
Loading profile data…Frequently asked questions about MOREPENLAB
What does Morepen Laboratories Limited (MOREPENLAB.NS) do?
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical device...
Where does MOREPENLAB.NS trade?
Morepen Laboratories Limited (MOREPENLAB.NS) trades on the National Stock Exchange of India.
What sector is MOREPENLAB.NS in?
Morepen Laboratories Limited (MOREPENLAB.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Morepen Laboratories Limited?
Sushil Suri is the chief executive officer of Morepen Laboratories Limited (MOREPENLAB.NS).
Where is Morepen Laboratories Limited headquartered?
Morepen Laboratories Limited is headquartered in India.
Does MOREPENLAB.NS pay a dividend?
Yes — Morepen Laboratories Limited (MOREPENLAB.NS) paid a trailing twelve-month dividend of INR 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did MOREPENLAB.NS go public?
Morepen Laboratories Limited (MOREPENLAB.NS) completed its initial public offering in 1996.